发明名称 Heterodimers of glutamic acid
摘要 Compounds of Formula (Ia);wherein R is a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl, a C1-C6 substituted or unsubstituted alkyl or —NR′R′,Q is C(O), O, NR′, S, S(O)2, C(O)2 (CH2)pY is C(O), O, NR′, S, S(O)2, C(O)2 (CH2)pZ is H or C1-C4 alkyl,R′ is H, C(O), S(O)2, C(O)2, a C6-C12 substituted or unsubstituted aryl, a C6-C12 substituted or unsubstituted heteroaryl or a C1-C6 substituted or unsubstituted alkyl, when substituted, aryl, heteroaryl and alkyl are substituted with halogen, C6-C12 heteroaryl, —NR′R′ or COOZ, which have diagnostic and therapeutic properties, such as the treatment and management of prostate cancer and other diseases related to NAALADase inhibition. Radiolabels can be incorporated into the structure through a variety of prosthetic groups attached at the X amino acid side chain via a carbon or hetero atom linkage.
申请公布号 US9309193(B2) 申请公布日期 2016.04.12
申请号 US201113271549 申请日期 2011.10.12
申请人 Molecular Insight Pharmaceuticals, Inc. 发明人 Babich John W.;Zimmerman Craig N.;Maresca Kevin P.
分类号 A61K51/04;A61K49/00;C07C275/24;C07B59/00;C07C275/16;C07C275/30;C07C311/19;C07D213/38 主分类号 A61K51/04
代理机构 K&L Gates LLP 代理人 K&L Gates LLP
主权项 1. A method of imaging one or more organs or tissues or both of a mammal comprising: (A) administering to a mammal an effective amount of a compound of Formula (I) wherein R is a phenyl moiety substituted with a radiohalogen, or —NHR′, Q is NH, Y is C(O), O, NR′, S(O)2, C(O)2, or (CH2)p, Z is H or C1-C4 alkyl, m is 3 or 4, n is 0 or 1, p is 0, 1, 2, 3, 4, 5 or 6, and R′ is a phenyl moiety substituted with a radiohalogen, or a pharmaceutically acceptable salt of the compound of Formula (I), which the compound binds Prostate Specific Membrane Antigen (PSMA); (B) obtaining an image; and (C) determining from the image the presence of PSMA.
地址 Cambridge MA US